India’s ‘Ozempic’ price war: Generic entry slashes costs of drugs by 90 percent
A fierce price war has erupted among Indian pharmaceutical companies after the Semaglutide patent expiry, with generics priced up to…
A fierce price war has erupted among Indian pharmaceutical companies after the Semaglutide patent expiry, with generics priced up to…
As affordable generic weight-loss drugs enter the Indian market, CDSCO has warned against self-medication and misleading advertisements. Regulators stress medical…